Connect with us

Hi, what are you looking for?

Latest News

Jill Biden has ‘small lesion’ above right eye, doctor says, will be removed

First Lady Jill Biden has a ‘small lesion’ above her right eye that was found during a routine appointment, according to the physician to the president.

Dr. Kevin O’Connor, physician to the president, said in a Wednesday evening letter that the lesion was found during a routine skin cancer screening.

O’Connor said that the lesion will be removed on Jan. 11, and the tissue will be examined.

‘During a routine skin cancer screening, a small lesion was found above the First Lady’s right eye. In an abundance of caution, doctors have recommended that it be removed,’ O’Connor said.

‘On Wednesday, January 11th at Walter Reed National Military Medical Center, the First Lady will undergo a common outpatient procedure known as Mohs surgery to remove and definitively examine the tissue. We will offer an update after the procedure is completed and we have more information,’ he added.

This post appeared first on FOX NEWS

You May Also Like


Inflation appears to be on the decline. The Personal Consumption Expenditures Price Index (PCEPI), which is the Federal Reserve’s preferred measure of inflation, grew...


Mimiq, Inc is announcing today the launch of their new product, Mimiq Track, at CES as part of their latest product line to operate...


On this week’s edition of Stock Talk with Joe Rabil, Joe looks at the longer-term picture for stocks like AAPL, TSLA, and more. He...

Latest News

Kevin McCarthy’s difficult road to becoming House speaker ended early Saturday morning after Republicans appeared to have miscounted the number of votes they needed...

Disclaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2023